Logo image of HLVX

HILLEVAX INC (HLVX) Stock Analyst Ratings

NASDAQ:HLVX - Nasdaq - US43157M1027 - Common Stock - Currency: USD

1.88  +0.03 (+1.62%)

After market: 1.88 0 (0%)

Buy % Consensus

46

ChartMill assigns a Buy % Consensus number of 46% to HLVX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 2.04. This target is 8.51% above the current price.
HLVX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about HLVX.
In the previous month the buy percentage consensus was at a similar level.
HLVX was analyzed by 7 analysts. More opinions would make the average more meaningful.
HLVX Historical Analyst RatingsHLVX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -36 -33 -30 -27 -24 -21 -18 -15 -12 -9 -6 -3 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.882.022.042.042.10 - 7.45% 8.51% 8.51% 11.70%
HLVX Current Analyst RatingHLVX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-03-31 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-08-12 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-07-09 Leerink Partners Downgrade Outperform -> Market Perform
2024-07-09 Stifel Downgrade Buy -> Hold
2024-07-09 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-07-08 Guggenheim Downgrade Buy -> Neutral
2024-07-08 JP Morgan Downgrade Overweight -> Neutral
2024-05-15 JP Morgan Maintains Overweight -> Overweight
2024-05-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-21 HC Wainwright & Co. Reiterate Buy -> Buy
2023-12-13 HC Wainwright & Co. Initiate Buy
2023-11-15 Guggenheim Maintains Buy -> Buy
2023-11-10 Stifel Maintains Buy -> Buy
2023-05-16 JP Morgan Maintains Overweight -> Overweight
2022-05-24 Guggenheim Initiate Buy
2022-05-24 SVB Leerink Initiate Outperform
2022-05-24 Stifel Initiate Buy
2022-05-24 JP Morgan Initiate Overweight